1 / 12

Vaccine Injury Analysis: VICP Update 2010

Updates on medical analysis of VICP claims, focusing on childhood vaccines, autism reviews, HPV claims, and shoulder injury cases. Demographics, trends, and concerns discussed.

nievesm
Download Presentation

Vaccine Injury Analysis: VICP Update 2010

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Medical Analysis Update: VICP Advisory Commission on Childhood Vaccines June 10-11, 2010 Rosemary Johann-Liang, MD Rjohann-liang@hrsa.gov

  2. Number of Petitions for Medical Analysis 5 year period: FY 2005-2009

  3. Claims filed to VICPComparing %age-bands 10 years apart

  4. FY 2009 Claims Filed to VICP

  5. FY 2010 8 months so far N=498 reports total N=155 are activated autism reviews 2010 Medical (MO) Reviews: New Reports

  6. 3/10-5/10 MO Reviews: Age

  7. 3/10-5/10 MO Reviews: Vaccines Alleged (non-autism)

  8. 3/10-5/10 MO Reviews: Adverse Events (non-autism)

  9. HPV Claim: Demographics • Total # of claims thus far since 2008 = 54 with 5 death claims • Average age = 16.5 years for all female claims with range (12 – 27 yrs) • Only one male claim (age over 50 years). • 39% had HPV x 1; 32% had HPV x 2 and 29% had HPV x 3 • 16% of total had other concurrent vaccines (meningococcal, hepatitis A, hepatitis B, and Tetanus-containing)

  10. HPV MO Reviews On-going: Injuries Claimed

  11. Shoulder Injury Case Series • Bodor M and Montalvo E. Vaccination-related shoulder dysfunction; Vaccine 25 (2007) 585-587 • Case reports of 2 patients; pain within 2 days following vaccination; injection too high on shoulder? • Medical Analysis of VICP Claims from 2006-2009; 11 claims identified with significant shoulder pain and dysfunction following vaccine administration

  12. Shoulder Series: Initial Analyses • 82% female; Mean age = 52 (range 29-83) • Vaccine Administered; 64% influenza; 36% tetanus-containing • Pain onset is less than 24 hrs in 91% from vaccine administration with 64% recalling immediate symptom onset. • Diagnoses: bursitis, rotator cuff injury, adhesive capsulitis • Concern: long-term sequelae • Concern: where and how administered

More Related